Unusual interleukin-1 and -6 expression in fetal cartilage is associated with placental abnormalities

Folia Histochemica et Cytobiologica

Volumn 48, Issue 1, 2010, Pages 30-36

  Burdan, Franciszek ^a   Szumilo, Justyna ^a   Korobowicz Markiewicz, Agnieszka ^a   Dyndor, Katarzyna ^a   Szumilo, Michal ^a   Klepacz, Robert ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

COX 1; COX 2; Cyclooxygenase inhibitor; Developmental toxicity; NSAID; Placental morphology; Pregnancy

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOENZYME; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE; PROTEIN; TOLMETIN; UREA; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIFICATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIPHYSEAL CARTILAGE; FEMALE; FETUS; FETUS (ANATOMY); FETUS DEVELOPMENT; GENE EXPRESSION; GIANT CELL; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; NONHUMAN; PLACENTA DISORDER; PLACENTA FUNCTION; PLACENTA WEIGHT; PRENATAL DRUG EXPOSURE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STAINING; UREA BLOOD LEVEL;

RATTUS;

EID: 77954358959     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0097-1     Document Type: Article

References (40)

1. Holsapple MP, West LJ, Landreth KS. Species comparison of anatomical and functional immune system development. Birth Defects Res B Dev Reprod Toxicol. 2003;68:321-334.
2. Bell MJ, Hallenbeck JM, Gallo V. Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res. 2004;56:541-546.
3. Thellin O, Heinen E. Pregnancy and the immune system: between tolerance and rejection. Toxicology. 2003;185:179-184.
4. Van Loveren H, Vos J, Putman E, Piersma A. Immunotoxicological consequences of perinatal chemical exposures: a plea for inclusion of immune parameters in reproduction studies. Toxicology. 2003;185:185-191.
5. Koch CA, Platt JL. T cell recognition and immunity in the fetus and mother. Cell Immunol. 2007;248:12-17.
6. Lewis SH, Perrin E. Pathology of the Placenta. 2 ed. New York: Churchill Livingstone; 1999.
7. Burdan F, Szumilo J, Marzec B, Klepacz R, Dudka J. Skeletal developmental effects of selective and nonselective cyclooxygenase-2 inhibitors administered through organogenesis and fetogenesis in Wistar CRL:(WI)WUBR rats. Toxicology. 2005;216:204-223.
8. Silen ML, Firpo A, Morgello S, Lowry SF, Francus T. Interleukin- 1 alpha and tumor necrosis factor alpha cause placental injury in the rat. Am J Pathol. 1989;135:239-244.
9. Christian MS. Test methods for assessing female reproductive and developmental toxicology. In: Hayes AW, ed Principles and Method of Toxicology. 4th ed, Philadelphia: Taylor & Francis; 2001:1301-1381.
10. Burdan F. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats--DFU and piroxicam study. Toxicology. 2005;211:12-25.
11. Burdan F. Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats. Birth Defects Res B Dev Reprod Toxicol. 2004;71:321-330.
12. Burdan F, Rozylo-Kalinowska I, Szumilo J, Dudka J, Klepacz R. Cyclooxygenase inhibitors affect bone mineralization in rat fetuses. Cells Tissues Organs. 2008;187:221-232.
13. Burdan F, Szumiło J, Gajjar B, et al. Immunoexpression of constitutive and inducible cyclo-oxygenase isoforms in the rat foetal and maternal digestive tract. Folia Morphol. 2008;67: 24-31.
14. de Rijk EP, van Esch E, Flik G. Pregnancy dating in the rat: placental morphology and maternal blood parameters. Toxicol Pathol. 2002;30:271-282.
15. Levario-Carrillo M, Olave ME, Corral DC, Alderete JG, Gagioti SM, Bevilacqua E. Placental morphology of rats prenatally exposed to methyl parathion. Exp Toxicol Pathol. 2004;55:489-496.
16. Burdan F, Chałas A, Szumiło J. Cyclooxygenase and prostanoids - biological implications. Postepy Hig Med Dosw. 2006;60:129-141.
17. McGiff JC. Vascular prostaglandin synthesis: the early days. Pharmacol Rep. 2006;58 (suppl 1):47-51.
18. Xu Y, Knipp GT, Cook TJ. Expression of cyclooxygenase isoforms in developing rat placenta, human term placenta, and BeWo human trophoblast model. Mol Pharm. 2005;2:481- 490.
19. Burdan F, Szumilo J, Klepacz R. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development. Reprod Toxicol. 2009;28: 239-44.
20. Campanile G, Neglia G, Di Palo R, et al. Relationship of body condition score and blood urea and ammonia to pregnancy in Italian Mediterranean buffaloes. Reprod Nutr Dev. 2006;46: 57-62.
21. Rhoads ML, Rhoads RP, Gilbert RO, Toole R, Butler WR. Detrimental effects of high plasma urea nitrogen levels on viability of embryos from lactating dairy cows. Anim Reprod Sci. 2006;91:1-10.
22. Abran D, Dumont I, Hardy P, et al. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development. Circ Res. 1997;80:463-472.
23. Yamazaki K, Endo T, Kitajima Y, et al. Elevation of both cyclooxygenase-2 and prostaglandin E2 receptor EP3 expressions in rat placenta after uterine artery ischemia-reperfusion. Placenta. 2006;27:395-401.
24. Głuszko P, Bieliñska A. Non-steroidal anti-inflammatory drugs and the risk of cardiovascular diseases: are we going to see the revival of cyclooxygenase-2 selective inhibitors? Pol Arch Med Wewn. 2009;119:231-235.
25. Roumie CL, Mitchel EF Jr, Kaltenbach L, Arbogast PG, Gideon P, Griffin MR. Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke. Stroke. 2008;39:2037- 2045.
26. Cammer W. Effects of TNFalpha on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res. 2000;864:213-219.
27. Korobowicz A. Biology of tumor necrosis factor type alpha (TNF-alpha). Pol Merkur Lekarski. 2006;21:358-361.
28. Arntzen KJ, Kjřllesdal AM, Halgunset J, Vatten L, Austgulen R. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med. 1998;26:17-26.
29. Kamiñski KA, Oledzka E, Białobrzewska K, Kozuch M, Musiał WJ, Winnicka MM. The effects of moderate physical exercise on cardiac hypertrophy in interleukin 6 deficient mice. Adv Med Sci. 2007;52:164-168.
30. Morisset J. Hormonal control of pancreatic growth during fetal, neonatal and adult life. Adv Med Sci. 2008;53:99-118.
31. Pietrzak A, Zalewska A, Chodorowska G, et al. Genes and structure of selected cytokines involved in pathogenesis of psoriasis. Folia Histochem Cytobiol. 2008;46:11-21.
32. Carbó N, López-Soriano FJ, Argilés JM. Tumour necrosis factor-alpha does not cross the rat placenta. Cancer Lett. 1998;128:101-104.
33. Debillon T, Gras-Leguen C, Vérielle V, et al. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr Res. 2000;47:736-742.
34. Yoon BH, Kim CJ, Romero R, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 1997;177:797-802.
35. Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev. 2009;6 (suppl 3):332-336.
36. Beekhuijzen M, Zmarowski A, Emmen H, Frieling W. To mate or not to mate: a retrospective analysis of two-generation studies for evaluation of criteria to trigger additional mating in the extended one-generation design. Reprod Toxicol. 2009;28:203-208.
37. Dang ZC, Rorije E, Esch TH, Muller A, Hakkert BC, Piersma AH. Retrospective analysis of relative parameter sensitivity in multi-generation reproductive toxicity studies. Reprod Toxicol. 2009;28:196-202.
38. Paszkiewicz-Gadek A, Porowska H, Sredziñska K. Expression of MUC1 mucin in full-term pregnancy human placenta. Adv Med Sci. 2008;53:54-58.
39. Barrow PC. Reproductive toxicity testing for pharmaceuticals under ICH. Reprod Toxicol. 2009;28:172-179.
40. Gebel T, Lechtenberg-Auffarth E, Guhe C. About hazard and risk assessment: regulatory approaches in assessing safety in the European Union chemicals legislation. Reprod Toxicol. 2009;28:188-195.